Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tachosil for Prevention of Symptomatic Lymphoceles in Gynecologic Cancer
NCT01470677Phase 3Completed
- Sponsor
- Ruhr University Bochum
- Start
- Nov 2011
- Primary completion
- Jan 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Phase 3, randomised, single-blind trial of tachosil in lymphocele, sponsored by Ruhr University Bochum. Primary endpoint: Incidence of symptomatic pelvic lymphoceles at 4 weeks. Started Nov 2011; status: completed.
02
Drugs
tachosil
03
Conditions
lymphocele
Beyond the preview
Go deeper on NCT01470677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01470677.